Concepedia
Statistics
Publications
3
Citations
297
H-Index
Active since
1996
Affiliations
Merck Biopharma Co., Ltd. (Japan)(Current)
California University of Pennsylvania
University of Kentucky
University of North Carolina at Chapel Hill
University of Pennsylvania
K. D. Kiel is an author at Merck Biopharma Co., Ltd. (Japan) specializing in radiation therapy, medicine, and oncology.
Publications per year
1996–2004
Early-stage breast cancer: arm edema after wide excision and breast irradiation.
K. D. Kiel, A W Rademacker · Radiology · 1996 · 130 citations
Medicine, Oncology, Surgery +17
A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer.
Stephen M. Hahn, Eric J. Bernhard, William F. Regine et al. · PubMed · 2002 · 88 citations
Medicine, Oncology, Pharmacology +14
A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer
Neil E. Martin, Thomas Brunner, K. D. Kiel et al. · Clinical Cancer Research · 2004 · 79 citations · Full text
Medicine, Oncology, Pharmacology +13
1–3 of 3